— Know what they know.
Not Investment Advice
Also trades as: HBC.OL (OSL) · $vol 0M

HOFBF OTC

Hofseth BioCare ASA
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -49.5% 5Y: -82.9%
$0.17
+0.00 (+0.00%)
 
OTC · Consumer Defensive · Packaged Foods · Tech Score Sell · Power 38 · $68.5M mcap · 206M float · 0.028% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$68.5M
52W Range0.1666-0.176
Volume67,500
Avg Volume57,000
Beta0.26
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJon Olav Odegard
Employees84
SectorConsumer Defensive
IndustryPackaged Foods
IPO Date2018-08-22
Keiser Wilhelms gate 24
Ålesund, MR 6003
NO
47 73 10 22 00
About Hofseth BioCare ASA

Hofseth BioCare ASA is a company specializing in the development and supply of premium, marine-derived ingredients for various applications in both human and animal health. Its market presence extends from Norway to an international scale. The company offers a diverse array of products. These include its general Brilliant salmon oil, alongside specialized formulations like OmeGo salmon oil, which is designed to support healthy cholesterol levels and cardiovascular function. ProGo, a rapidly absorbing salmon protein hydrolysate powder, serves as an efficient protein supplement. For bone and joint support, CalGo is a marine calcium powder developed to bolster cartilage function and promote overall joint health. Addressing beauty and wellness needs, CollaGo is a collagen peptide powder aimed at enhancing the strength and appearance of hair, skin, and nails. Rounding out their offerings is PetGo, a non-soluble protein for animal applications. Hofseth BioCare employs a multi-faceted distribution strategy, reaching customers through a network of independent distributors, agents, and its dedicated internal sales team. Furthermore, the firm maintains a significant research collaboration with the Stanford University School of Medicine. This partnership involves jointly conducting pre-clinical and clinical studies focused on conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, Hofseth BioCare ASA maintains its corporate headquarters in Ålesund, Norway.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms